drugset / Trial / NCT01832753

Treatment Trial of Subclinical Hypothyroidism in Down Syndrome

NCT01832753

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research study is to learn about the effects of treating subclinical hypothyroidism (SCH) with thyroid hormone replacement in children and adolescents with Down syndrome (DS). We hypothesize that treatment of SCH with thyroid hormone replacement will improve cardiometabolic health and quality of life.

Timeline

Start
2013-01
Primary completion
2017-10-18
Completion
2017-10-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levothyroxine Other / unclassified 0.5 ug/kg
Comparator Levothyroxine Other / unclassified 1 ug/kg